Abstract
A 61-year-old woman was referred to our hospital with epigastralgia and appetite loss. Barium examination and upper gastrointestinal endoscopy revealed uneven erythematous mucosa with multiple elevated lesions from the gastric fornix to the upper corpus. Abdominal computed tomography showed thickening of the wall of the fornix and swelling of perigastric lymph nodes, but whole-body gallium scintigraphy and bone marrow examination did not indicate further involvement. Biopsy specimens showed diffuse infiltration of large atypical lymphoid cells in which Epstein-Barr virus (EBV) was detected by in situ hybridization. Diffuse large B-cell lymphoma (DLBCL), stage II1, was diagnosed. Combination chemotherapy [cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP)], was given, and this was followed by radiotherapy. Partial remission was achieved by chemotherapy, but the disease progressed rapidly during radiotherapy. Because the reported prognosis of EBV-positive DLBCL is unfavorable, the therapeutic strategy for EBV-positive gastric DLBCL should be considered carefully.
Similar content being viewed by others
References
Sano T, Sasako M, Kinoshita T, Katai H, Maruyama K, Takenaka T, et al. Total gastrectomy for primary gastric lymphoma at stages IE and IIE: a prospective study of fifty cases. Surgery. 1997;121:501–5.
Ishikura S, Tobinai K, Ohtsu A, Nakamura S, Yoshino T, Oda I, et al. Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II1, diffuse large B-cell lymphoma of the stomach. Cancer Sci. 2005;96:349–52.
Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Groqan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin’s lymphoma. N Engl J Med. 1998;339:21–6.
Avilés A, Nambo MJ, Neri N, Huerta-Guzmán J, Cuadra I, Alvarado I, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg. 2004;240:44–50.
Koch P, Grothaus-Prinke B, Hiddenmann W, Willich N, Reers B, del Valle F, et al. Primary lymphoma of the stomach: three-year results of a prospective multicenter study. The German Multicenter Study Group on GI-NHL. Ann Oncol. 1997;8(Suppl 1):85–8.
Haim N, Leviov M, Ben-Arieh Y, Epelbaum R, Freidin N, Reshef R, et al. Intermediate and high-grade gastric non-Hodgkin’s lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy. Leuk Lymphoma. 1995;17:321–6.
Lybeert ML, De Neve W, Vrints LW, Coen V, Coeberqh JW. Primary gastric non-Hodgkin’s lymphoma stage IE and IIE. Eur J Cancer. 1996;32A:2306–11.
Yoshino T, Nakamura S, Matsuno Y, Ochiai A, Yokoi T, Kitadai Y, et al. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Cancer Sci. 2006;97:163–6.
Jarrett RF, Stark GL, White J, Anqus B, Alexander FE, Krajewski AS, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classical Hodgkin lymphoma: a population-based study. Blood. 2005;106:2444–51.
Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, Yatabe Y, et al. Senile EBV + B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol. 2003;27:16–26.
Hsieh PP, Tung CL, Chan AB, Liao JB, Wang JS, Tseng HH, et al. EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma. Am J Clin Pathol. 2007;128:579–84.
Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. Clin Cancer Res. 2002;8:29–34.
Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol. 2000;111:239–46.
van Esser JW, Niesters HG, Thijsen SF, Meijer E, Osterhaus AD, Wolthers KC, et al. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol. 2001;113:814–21.
Solassol J, Kreuzer KA, Lass U, Schmidt CA. Epstein-Barr virus DNA quantitation assessed by a real-time polymerase chain reaction in a case of Burkitt’s lymphoma. Leuk Lymphoma. 2001;41:669–73.
Chuang HC, Lay JD, Hsieh WC, Su IJ. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci. 2007;98:1281–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sumida, T., Kitadai, Y., Masuda, H. et al. Rapid progression of Epstein-Barr-virus-positive gastric diffuse large B-cell lymphoma during chemoradiotherapy: a case report. Clin J Gastroenterol 1, 105–109 (2008). https://doi.org/10.1007/s12328-008-0020-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-008-0020-5